This topic contains a solution. Click here to go to the answer

Author Question: To ratify an agreement a principal must know: a. the important facts of the agreement b. a general ... (Read 124 times)

serike

  • Hero Member
  • *****
  • Posts: 542
To ratify an agreement a principal must know:
 a. the important facts of the agreement b. a general outline of the agreement
  c. the name of the agent
  d. the agent for at least two years
  e. none of the other choices are correct

Question 2

Fifth Amendment. The federal government was investigating a corporation and its employees. The alleged criminal wrongdoing, which included the falsification of corporate books and records, occurred between 1993 and 1996 in one division of the corporation. In 1999, the corporation pled guilty and agreed to cooperate in an investigation of the individuals who might have been involved in the improper corporate activities. Doe I, Doe II, and Doe III were officers of the corporation during the period in which the illegal activities occurred and worked in the division where the wrongdoing took place. They were no longer employed by the corporation, however, when, as part of the subsequent investigation, the government asked them to provide specific corporate documents in their possession. All three asserted the Fifth Amendment privilege against self-incrimination. The government asked a federal district court to order the three to produce the records. Corporate employees can be compelled to produce corporate records in a criminal proceeding because they hold the records as representatives of the corporation, to which the Fifth Amendment privilege against self-incrimination does not apply. Should former employees also be compelled to produce corporate records in their possession? Why or why not?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kingdude89

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

a

Answer to Question 2

Fifth Amendment
The court held that the act of testimonial production on behalf of a person who is no longer with the corporation is self incrimination in its classic sense of the word, and the Constitution does not permit it. The government appealed to the U.S. Court of Appeals for the Second Circuit, which affirmed the holding of the lower court. The appellate court acknowledged that a current corporate employee, . . . who had been individually subpoenaed to produce corporate books and records, could not invoke the Fifth Amendment to refuse production even though the documents might provide the government with evidence that could incriminate him. The court reasoned that here, in the case of ex-employees, ince Doe I, Doe II and Doe III are no longer employed by the corporation whose documents the government seeks, and therefore do not hold the corporate documents in a representational capacity, . . . each may claim a Fifth Amendment act of production privilege.




serike

  • Member
  • Posts: 542
Reply 2 on: Jun 24, 2018
Wow, this really help


olderstudent

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Gracias!

 

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library